{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:15:17Z","timestamp":1774667717520,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05915-8","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T09:29:43Z","timestamp":1759570183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk stratification of high-risk muscle invasive upper urinary tract urothelial carcinoma: multi-institutional study"],"prefix":"10.1007","volume":"43","author":[{"given":"Hao-Lun","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Lung","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Chou","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hsiu","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Huei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Jen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"issue":"1","key":"5915_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, Capoun O et al (2023) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol 84(1):49\u201364","journal-title":"Eur Urol"},{"key":"5915_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/UROS.UROS_58_22","volume":"33","author":"HL Luo","year":"2022","unstructured":"Luo HL, Chen TS, Wu WJ (2022) The cancer behavior and current treatment strategy for upper urinary tract cancer. Urol Sci 33:161\u2013169","journal-title":"Urol Sci"},{"issue":"1","key":"5915_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/us9.0000000000000018","volume":"35","author":"SG Wang","year":"2024","unstructured":"Wang SG, Luo HL, Wang HJ et al (2024) Segmental ureterectomy outcome of upper tract urothelial carcinoma in a high endemic area: a Taiwan nationwide collaborative study. Urol Sci 35(1):e000018","journal-title":"Urol Sci"},{"issue":"10232","key":"5915_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet 395(10232):1268\u20131277","journal-title":"Lancet"},{"key":"5915_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01659","author":"AJ Birtle","year":"2024","unstructured":"Birtle AJ, Jones R, Chester J et al (2024) Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: final results of the POUT trial. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.23.01659","journal-title":"J Clin Oncol"},{"issue":"2","key":"5915_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clgc.2023.08.001","volume":"22","author":"M Ferro","year":"2023","unstructured":"Ferro M, Chiujdea S, Vartolomei MD et al (2023) Advanced age impacts survival after radical nephroureterectomy for upper tract urothelial carcinoma. Clin Genitourin Cancer 22(2):27\u201337","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"5915_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.urology.2008.04.032","volume":"72","author":"C Bolenz","year":"2008","unstructured":"Bolenz C, Fern\u00e1ndez MI, Trojan L et al (2008) Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology 72(2):364\u2013369","journal-title":"Urology"},{"key":"5915_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00481","volume":"10","author":"TS Zhai","year":"2020","unstructured":"Zhai TS, Jin L, Feng LM et al (2020) Perioperative chemotherapy on survival in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy: a population-based study. Front Oncol 10:481","journal-title":"Front Oncol"},{"key":"5915_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijsu.2020.02.015","volume":"76","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Yao Z, Zhu X, Wu B, Bai S (2020) Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: a propensity score-matched case control study. Int J Surg 76:28\u201334. https:\/\/doi.org\/10.1016\/j.ijsu.2020.02.015","journal-title":"Int J Surg"},{"key":"5915_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.984014","volume":"12","author":"H Zhao","year":"2022","unstructured":"Zhao H, Jiao B, Liu K et al (2022) Intravesical recurrence factors and outcome after radical nephroureterectomy for upper tract urothelial carcinoma: multivariate analysis with propensity score matching. Front Oncol 12:984014. https:\/\/doi.org\/10.3389\/fonc.2022.984014","journal-title":"Front Oncol"},{"issue":"6","key":"5915_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T, Granger B, Colin P et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67(6):1122\u20131133. https:\/\/doi.org\/10.1016\/j.eururo.2014.11.035","journal-title":"Eur Urol"},{"issue":"6","key":"5915_CR12","doi-asserted-by":"publisher","first-page":"e1055","DOI":"10.1016\/j.clgc.2017.07.009","volume":"15","author":"CH Lee","year":"2017","unstructured":"Lee CH, Ku JY, Jeong CW et al (2017) Predictors for intravesical recurrence following radical nephroureterectomy for upper tract urothelial carcinoma: a national multicenter analysis. Clin Genitourin Cancer 15(6):e1055\u2013e1061. https:\/\/doi.org\/10.1016\/j.clgc.2017.07.009","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"5915_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4067\/S0034-98872022000200172","volume":"150","author":"PA Rojas","year":"2022","unstructured":"Rojas PA, Bravo JC, Gallegos H, Z\u00fa\u00f1iga \u00c1, Francisco IS (2022) Tabaquismo y tumores mayores de 2 cent\u00edmetros son predictores de Mortalidad En Pacientes sometidos a nefro-ureterectom\u00edas Por carcinoma de Urotelio Alto [Prognostic factors in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy]. Rev Med Chil 150(2):172\u2013177. https:\/\/doi.org\/10.4067\/S0034-98872022000200172. (Spanish)","journal-title":"Rev Med Chil"},{"issue":"9","key":"5915_CR14","doi-asserted-by":"publisher","first-page":"410.e1","DOI":"10.1016\/j.urolonc.2022.03.006","volume":"40","author":"X Li","year":"2022","unstructured":"Li X, Li H, Gao XS et al (2022) Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma. Urol Oncol 40(9):410.e1-410.e10","journal-title":"Urol Oncol"},{"key":"5915_CR15","unstructured":"Eble JN, Sauter G, Epstein JI et al (2004) Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours, IARCC Press, Lyon"},{"key":"5915_CR16","volume-title":"American Joint Commission On Cancer. AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) American Joint Commission On Cancer. AJCC cancer staging manual, 7th edn. Springer, New York","edition":"7"},{"issue":"23","key":"5915_CR17","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.3390\/jcm12237273","volume":"12","author":"J Ye","year":"2023","unstructured":"Ye J, Wu Q, Liao X, Zheng L, Wei Q, Bao Y (2023) Advanced age may not be an absolute contraindication for radical nephroureterectomy in patients with upper tract urothelial carcinoma: a single-center case series and a systematic review with meta-analyses. J Clin Med 12(23):7273. https:\/\/doi.org\/10.3390\/jcm12237273","journal-title":"J Clin Med"},{"key":"5915_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.766576","volume":"11","author":"IHA Chen","year":"2022","unstructured":"Chen IHA, Chang CH, Huang CP et al (2022) Factors predicting oncological outcomes of radical nephroureterectomy for upper tract urothelial carcinoma in Taiwan. Front Oncol 11:766576. https:\/\/doi.org\/10.3389\/fonc.2021.766576","journal-title":"Front Oncol"},{"issue":"4","key":"5915_CR19","doi-asserted-by":"publisher","first-page":"e751","DOI":"10.1016\/j.clgc.2018.01.0141","volume":"16","author":"H Emamekhoo","year":"2018","unstructured":"Emamekhoo H, Dhillon P, Gopalakrishnan D et al (2018) Prognostic factors and risk stratification in invasive upper tract urothelial carcinoma. Clin Genitourin Cancer 16(4):e751\u2013e760. https:\/\/doi.org\/10.1016\/j.clgc.2018.01.0141","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"5915_CR20","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/biomedicines10061340","volume":"10","author":"TH Kim","year":"2022","unstructured":"Kim TH, Sung HH, Oh JJ et al (2022) Clinical implication of preoperative renal function on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. Biomedicines 10(6):1340","journal-title":"Biomedicines"},{"issue":"5","key":"5915_CR21","first-page":"547","volume":"10","author":"K Kuroda","year":"2019","unstructured":"Kuroda K, Asakuma J, Horiguchi A et al (2019) Chronic kidney disease and positive surgical margins as prognosticators for upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy. Mol Clin Oncol 10(5):547\u2013554","journal-title":"Mol Clin Oncol"},{"key":"5915_CR22","doi-asserted-by":"publisher","first-page":"766576","DOI":"10.3389\/fonc.2021.766576","volume":"11","author":"IA Chen","year":"2022","unstructured":"Chen IA, Chang CH, Huang CP et al (2022) Factors predicting oncological outcomes of radical nephroureterectomy for upper tract urothelial carcinoma in Taiwan. Front Oncol 11:766576","journal-title":"Front Oncol"},{"issue":"5","key":"5915_CR23","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/j.clgc.2016.02.008","volume":"14","author":"C Liang","year":"2016","unstructured":"Liang C, Chi R, Huang L et al (2016) Upper tract urothelial carcinomas accompanied by previous or synchronous nonmuscle-invasive bladder cancer and preoperative hydronephrosis might have worse oncologic outcomes after radical nephroureterectomy. Clin Genitourin Cancer 14(5):e469\u2013e477","journal-title":"Clin Genitourin Cancer"},{"issue":"10","key":"5915_CR24","first-page":"3503","volume":"31","author":"E Brunocilla","year":"2011","unstructured":"Brunocilla E, Pernetti R, Martorana G (2011) The prognostic role of lymphovascular invasion in urothelial-cell carcinoma of upper and lower urinary tract. Anticancer Res 31(10):3503\u20133506","journal-title":"Anticancer Res"},{"issue":"2","key":"5915_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jso.24801","volume":"117","author":"K Matsuo","year":"2018","unstructured":"Matsuo K, Wong KK, Fotopoulou C et al (2018) Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. J Surg Oncol 117(2):236\u2013244","journal-title":"J Surg Oncol"},{"issue":"3\u20134","key":"5915_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000433583","volume":"82","author":"MA Aleskandarany","year":"2015","unstructured":"Aleskandarany MA, Sonbul SN, Mukherjee A, Rakhaet EA (2015) Molecular mechanisms underlying lymphovascular invasion in invasive breast cancer. Pathobiology 82(3\u20134):113\u2013123","journal-title":"Pathobiology"},{"key":"5915_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4103\/UROS.UROS_112_21","volume":"33","author":"KA Glorius Tampubolon","year":"2022","unstructured":"Glorius Tampubolon KA, Pramod SV, Safriadi F, Fitriana MN, Hernowo BS (2022) Correlations of tumor depth and width with lymphovascular invasion in non-muscle invasive bladder cancer. Urol Sci 33:77\u201381","journal-title":"Urol Sci"},{"issue":"6","key":"5915_CR28","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.eururo.2012.06.029","volume":"63","author":"M Rink","year":"2013","unstructured":"Rink M, Xylinas E, Margulis V et al (2013) Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol 63(6):1082\u20131090","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05915-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:02:13Z","timestamp":1767999733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5915"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05915-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The collaborative study protocol was reviewed and approved by the Ethics Committee of the Institutional Review Board of Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (12-X-004). Signed informed consent was waived because of the retrospective design of the study, and no patient identifying information was collected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"594"}}